Kronos Bio, Inc. (KRON) Net Income (Loss) Attributable to Parent USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Kronos Bio, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2019 to 2024.
  • Kronos Bio, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$30 M, a 14.2% decline year-over-year.
  • Kronos Bio, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$116 M, a 5.51% increase year-over-year.
  • Kronos Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$113 M, a 15.4% increase from 2022.
  • Kronos Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$133 M, a 11.8% increase from 2021.
  • Kronos Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$151 M, a 70.8% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$116 M -$30 M -$3.72 M -14.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$113 M -$25.3 M +$6.46 M +20.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 -$119 M -$31.4 M +$882 K +2.73% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$120 M -$29.7 M +$3.16 M +9.61% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-13
Q1 2023 -$123 M -$26.2 M +$10 M +27.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$133 M -$31.8 M +$30.6 M +49% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$164 M -$32.3 M +$1.35 M +4.01% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$165 M -$32.9 M -$3.85 M -13.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-13
Q1 2022 -$161 M -$36.3 M -$10.2 M -39% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-13
Q4 2021 -$151 M -$62.3 M +$26.1 M +29.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 -$177 M -$33.6 M +$6.11 M +15.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$183 M -$29.1 M -$20.5 M -239% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-08
Q1 2021 -$163 M -$26.1 M -$19.1 M -273% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-08
Q4 2020 -$144 M -$88.4 M -$72.3 M -449% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-23
Q3 2020 -$71.4 M -$39.7 M -$35.7 M -890% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$35.7 M -$8.58 M -$5.07 M -144% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-09
Q1 2020 -$30.6 M -$7 M -$3.87 M -123% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-09
Q4 2019 -$26.8 M -$16.1 M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-23
Q3 2019 -$4.01 M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-18
Q2 2019 -$3.51 M Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-18
Q1 2019 -$3.13 M Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.